about
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopiEffects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary interventionWhole blood viscosity measurement in acute myocardial infarction: feasibility and significanceNitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1)Model-based determination of cut-off values for left ventricular hypertrophy from echocardiographic myocardial mass data.Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris.[Contribution of echocardiography to the diagnosis of non-obstructive cardiomyopathes. A comparison with hemodynamic and arteriographic data][Should all cases of aortic valve stenosis be surgically treated?]The role of percutaneous transluminal coronary angioplasty in heart transplant recipients.Prevalence of patent foramen ovale in patients with stroke.Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery.[Echocardiographic study of the left ventricle in aortic insufficiency. Comparison with the data of clinical development and hemodynamic results][Echocardiographic study of the left ventricle after single aortic valve replacement. Comparison with preoperative hemodynamic and angiographic data][Comparison of hemodynamic and histological data in hypertrophic subvalvular aortic stenosis. Therapeutic discussion (author's transl)][Angiographic morphological study of the left ventricle in obstructive cardiomyopathy. Comparison with haemodynamic data (author's transl)]Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.Evidence of the inaccuracy of standard echocardiographic and angiographic criteria used for the recognition of true and "false" left ventricular inferior aneurysms.[Echocardiographic diagnosis of obstructive myocardiopathies: study of the systolic anterior motion of the mitral valve and septal hypertrophy as compared with the hemodynamic and mechanographic findings. Evolution under medical treatment][Mitral valvuloplasty during the 4th month of pregnancy. Fetal protection with a lead mantle].Emergency percutaneous coronary dilatation for acute myocardial infarction in Behçet's disease.Diagnosis of primary cardiac sarcoma. Report of 4 cases and review of the literature.[Recurrent ventricular tachycardia and parchment right ventricle in the adult. Anatomical and clinical report of 2 cases][Echocardiographic study of the Wolff-Parkinson-White syndrome][Echocardiographical, hemodynamic and anatomical features of calcification of the mitral ring][Myocardial infarction and heterozygous sickle cell anemia. Apropos of 2 cases][An echocardiographic study of the internal dimensions of the left ventricle. Effect of sublingual trinitrine and of a microcapsule of trinitrine (author's transl)][Coronary stenosis after radiotherapy. Clinical study of 5 cases and review of the literature][Paradoxical displacement of the interventricular septum with impairment of filling of the left ventricle. Echocardiographic and hemodynamic diagnosis. Apropos of 3 cases]Long-term treatment of congestive heart failure with captopril.[Evolution of the primary successes of percutaneous aortic valvuloplasty].Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteries.Lack of platelet-activating factor release during reversible myocardial ischaemia.A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention.[Diagnostic value of hemodynamic and angiographic studies in right medioventricular subinfundibulaire stenosis (author's transl)][Atypical forms of Ebstein's disease: value and limitations of ultrasonography and cardiac catheterization (author's transl)][Thrombosis caused by active rapamycin stents]Results of percutaneous catheter valvuloplasty for calcified aortic stenosis in the elderly.Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes.[Search for emboligenic heart disease in case of ischemic cerebral accidents][Phase variations in the left coronary transstenotic pressure gradient before and after dilatation by percutaneous coronary angioplasty]
P50
Q28166874-0DD9CC70-8DC0-43A3-A6BB-8DE047921D36Q28183625-DA41D6C7-C544-44BB-BFF2-550DF1BCA6F8Q28190829-A7DF1B9F-743F-46B6-B0B7-F41C9E99E071Q28329408-0ACD1504-A0B0-4B80-83D5-6AB7FC6E8D8CQ30828751-8543CA5B-59E7-46C1-87AA-77F1053E84A8Q31825771-154F856C-C204-4278-86E3-D1842471A8CFQ31924158-E60499E3-4CFE-4AB9-8592-EE72742362BCQ33173887-ECCAB2FD-1333-4567-93F5-C1EFCDD0188EQ33950478-68E398C7-8CAB-4F7A-84C6-4B94FB7C6701Q34049700-38E3FC5D-1F9E-4EFA-9372-677B521A9F13Q35371420-6BCA4025-6606-41E8-9BDA-4537DB206EE8Q36503494-E810AA9E-2BF5-4002-952F-998673B4B050Q36629430-1BCB83E8-D5BB-46A0-8F95-4E6370264AB4Q36653040-5F116E2F-5B9F-48B2-8701-1585700A34C9Q36653743-4FE5D3EC-E810-4DBC-AD00-DFDC41D82BE8Q37875878-1DCED53B-9F38-421C-8E35-738E815E1DF8Q39236732-85A88CEF-4855-401F-89E0-9EDAEC543056Q39267532-CAA39CA4-DEF7-4CB6-8EA2-AC81FF22D626Q39511160-CAEB0B47-5DF9-4177-877B-2BC4D4E7B6A1Q39536048-3D535E0A-9F95-4139-A7B1-05CA048A1DF2Q39551865-D4BBED22-6334-49E5-87C4-3786776FBBF7Q39632537-04DE6699-0189-496F-9A9C-6D746DA9279BQ39648203-71BFEB3A-4068-45A3-931E-FA73760C6167Q39703126-2FB249E2-0139-400D-B0FA-2379EB2298BFQ41245764-BCC7BF5D-E9F7-402F-A0D4-F3315C28DCF2Q41289604-CCF3865E-957E-48FA-A338-DF7F5453E81FQ41382796-38B95125-28AD-4884-AFDE-291891197F4BQ41385882-0D9897E1-C945-45ED-9931-187857489D33Q41829898-39F150AC-49FD-4777-A181-851CDA5A5181Q43742668-807B2943-3B0B-4806-A211-5A191A2C99F8Q43880430-D5CE8370-39B5-4A53-8045-7D589FB8B6E8Q44219746-C1E8445C-A4C1-4A83-B5BA-094A22F55045Q44244531-D421C7C9-3154-4687-96C4-F6DCE5E97CA6Q44275599-A852F195-3571-4B07-9F05-32BB9AECF9EAQ44686576-9DB3B588-BA09-43DE-92C7-370BB5F538C1Q44806272-4778D2F2-8FA8-4D90-9333-DD9DFADCEB2DQ44835592-75108E1F-7A1C-4EE3-94E1-3DB4B2BA27E2Q44839236-036F624C-9411-48AB-8DCD-58537AFA1CDFQ45128244-AC9F5FA3-FCB0-42CA-9EB6-32E1DD89E949Q46004210-2E07F036-86FA-49D5-911F-B1D5901A6C2F
P50
description
physician
@en
name
Gérard Drobinski
@en
Gérard Drobinski
@nl
type
label
Gérard Drobinski
@en
Gérard Drobinski
@nl
altLabel
Drobinski G
@en
Drobinski G.
@en
Drobinski
@en
G Drobinski
@en
G. Drobinski
@en
prefLabel
Gérard Drobinski
@en
Gérard Drobinski
@nl
P106
P19
P21
P31
P5375
P569
1945-09-15T00:00:00Z
P570
2005-07-24T00:00:00Z